Aptose Biosciences Inc. (APTO)

Number of records: 7
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
28-Oct-19 1:59 PM
View: 
Rice William G.
Chairman, President & CEO
Director
Aptose Biosciences Inc. (APTO) 24-Oct-19Private Purchase 10,000$1.92$19,200.007%
153.01K to 163.01K
07-Jun-19 2:03 PM
View: 
Chow Gregory K.
Senior VP & CFO
Aptose Biosciences Inc. (APTO) 05-Jun-19Market Purchase 7,500$1.84$13,815.006%
127.01K to 134.51K
< 1%
05-Jun-19 1:21 PM
View: 
Marango Jotin
Senior VP, Chief Bus. Officer
Aptose Biosciences Inc. (APTO) 03-Jun-19Grant 80,000----100%
0 to 80.0K
19-Apr-19 2:35 PM
View: 
Rice William G.
Chair, President & CEO
Director
Aptose Biosciences Inc. (APTO) 18-Apr-19Market Purchase 10,000$1.85$18,507.007%
143.01K to 153.01K
(1%)
20-Mar-19 2:19 PM
View: 
Platzer Erich
Director
Aptose Biosciences Inc. (APTO) 19-Mar-19Market Sale 20,000$2.19$43,805.0017%
115.0K to 135.0K
(< 1%)
15-Mar-19 4:35 PM
View: 
Rice William G.
Chair, President & CEO
Director
Aptose Biosciences Inc. (APTO) 14-Mar-19Market Purchase 10,000$1.90$18,993.008%
133.01K to 143.01K
< 1%
14-Mar-19 5:32 PM
View: 
Chow Gregory K.
Senior VP & CFO
Aptose Biosciences Inc. (APTO) 13-Mar-19Market Purchase 15,000$1.75$26,322.0013%
112.01K to 127.01K
3%